account_name,fit,urgency,total,fit_reason,urgency_reason,urgency_source,trigger_summary,sec_matched_total,sec_examples,patent_matched_total,patent_examples,job_target_roles
AstraZeneca,5.0,3.0,21.0,CAR-T trial,"RECRUITING in high urgency phase (PHASE1,PHASE2)",clinicaltrials,"trial_candidate: A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subje | trial_candidate: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Posit | trial_candidate: Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors",0,[],0,[],"[""Clinical Scientist / Early Clinical Development Lead (Phase 1)"", ""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development""]"
Pfizer,4.0,3.0,19.0,molecule match: elranatamab,RECRUITING in high urgency phase (PHASE1),clinicaltrials,"trial_candidate: A Study to Learn About Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With D | trial_candidate: MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (M | trial_candidate: A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myelo",0,[],0,[],"[""Clinical Scientist / Early Clinical Development Lead (Phase 1)"", ""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development""]"
GSK,1.0,0.0,4.0,no trials,no trials and no relevant sec/patent signals,none,,0,[],0,[],"[""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development"", ""Clinical Scientist / Early Clinical Development Lead (Phase 1)""]"
